Elsevier

Epilepsy & Behavior

Volume 7, Supplement 1, September 2005, Pages 1-64
Epilepsy & Behavior

Treatment of epilepsy in adults: expert opinion, 2005

https://doi.org/10.1016/j.yebeh.2005.06.001Get rights and content

Abstract

Rationale

Over the past decade, there has been a proliferation of new therapies for the treatment of epilepsy. Faced with this growing list of options, clinicians must decide what therapy, or combination of therapies, is best for a given individual. Although controlled clinical trials exist for each treatment option, the answer to these questions may remain unclear. In 2000, a survey of expert opinion was done to address questions concerning which treatment options might be best in a number of clinical situations. We surveyed a group of US epileptologists again in 2004 and compared the results of the two surveys.

Methods

We sent a questionnaire on the treatment of adolescent and adult epilepsy syndromes to a group of opinion leaders in the field of epilepsy. The questions were formatted to simulate real-world clinical situations in the treatment of symptomatic localization related epilepsy (SLRE) and idiopathic generalized epilepsy (IGE). The experts were asked to rate treatment options based on a modified RAND 9-point scale (with “9” most appropriate and “1” least appropriate). Statistical analysis of data was performed as defined by the expert consensus method. The results were used to develop user-friendly recommendations concerning overall treatment strategies and choice of specific medications.

Results

Of the 48 experts to whom the survey was sent, 43 (90%) responded; 29 (67%) of the respondents had also participated in the first survey. For initial monotherapy for IGE (generalized tonic-clonic [GTC], absence, and myoclonic seizures), valproate was rated as treatment of choice. For IGE-GTC seizures, lamotrigine and topiramate were also identified as usually appropriate for initial monotherapy. For IGE-absence seizures, ethosuximide was also a treatment of choice, and lamotrigine was usually appropriate. For SLRE, the experts were again asked to rate treatment options based on seizure type: simple partial seizures (SPS), complex partial seizures (CPS), and secondarily generalized tonic-clonic seizures (SGTC). In SLRE-SPS and SLRE-SGTC, carbamazepine and oxcarbazepine were treatments of choice, with lamotrigine and levetiracetam also usually appropriate. In SLRE-CPS, carbamazepine, lamotrigine. and oxcarbazepine were treatments of choice, while levetiracetam was also usually appropriate. For women who are pregnant or trying to conceive, lamotrigine was treatment of choice for both syndrome types. In the elderly, whether medically stable or ill, the treatment of choice was lamotrigine, while levetiracetam was also usually appropriate (along with gabapentin for persons with comorbid medical illness). In persons with HIV and epilepsy, lamotrigine and levetiracetam were usually appropriate. In people with both epilepsy syndromes who have depression, lamotrigine was treatment of choice. In a person with seizures and renal disease, lamotrigine was usually appropriate for both syndromes, with valproate also usually appropriate for IGE. In patients with hepatic disease, levetiracetam and lamotrigine were usually appropriate for IGE; in SLRE, levetiracetam was treatment of choice, with gabapentin also usually appropriate.

Conclusions

Although the panel of experts reached consensus on many treatment options, there are limitations to these types of data. Despite this, the expert consensus method concisely summarizes expert opinion, and this opinion may be helpful in situations in which the medical literature is scant or lacking. The information in this report should be evaluated in conjunction with evidence-based findings.

References (75)

  • W.H. Theodore

    Felbamate

  • J.J. Cereghino et al.

    Levetiracetam for partial seizures: results of a double-blind randomized clinical trial

    Neurology

    (2000)
  • H.S. White

    Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs

    Epilepsia

    (1999)
  • J.W. Wheless et al.

    New formulations of drugs in epilepsy

    Expert Opin Pharmacother

    (1999)
  • B.J. Wilder

    Vagal nerve stimulation

  • E.P.G. Vining

    Ketogenic diet

  • H. Shmizu et al.

    Use of clobazam for the treatment of refractory complex partial seizures

    Seizure

    (2003)
  • M.J. Brodie

    Management strategies for localization-related seizures

    Epilepsia

    (2001)
  • Montenegro MA, Cendes F, Noronha AL, Mory SB, Carvalho MI, Marques LH, Guerreiro CA. Efficacy of clobazam as add-on...
  • E.A. Thiele

    Managing epilepsy in tuberous sclerosis

    J Child Neurol

    (2004)
  • S. Wiebe et al.

    Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized controlled trial of surgery for temporal lobe epilepsy

    N Engl J Med

    (2001)
  • S. Wiebe

    Early epilepsy surgery

    Curr Neurol Neurosci Rep

    (2004)
  • Beydoun A, Uthman BM, Kugler AR, Greiner MJ, Knapp LE, Garofalo EA; Pregabalin 1008-009 Study Group. Safety and...
  • Arroyo S, Anhut H, Kugler AR, Lee CM, Knapp LE, Garofalo EA, Messmer S; Pregabalin 1008-011 International Study Group....
  • J.A. French et al.

    Dose-response trial of pregabalin adjunctive therapy in patients with partial seizures

    Neurology

    (2003)
  • M.D. Privitera

    Evidence-based medicine and antiepileptic drugs

    Epilepsia

    (1999)
  • P.R. Williamson et al.

    Individual patient data meta-analysis of randomized anti-epileptic drug monotherapy trials

    J Eval Clin Pract

    (2000)
  • D.A. Kahn et al.

    Consensus methods in practice guideline development: A review and description of a new method

    Psychpharmacol Bull

    (1997)
  • Dalkey NC. The Delphi method: an experimental study of group opinion. Santa Monica, CA: RAND Corp.; 1969. Publication #...
  • S.H. Woolfe

    Practice guidelines, a new reality in medicine

    Arch Intern Med

    (1992)
  • R.H. Brook et al.

    A method for the detailed assessment of the appropriateness of medical technologies

    Int J Tech Assess Health Care

    (1986)
  • A. Frances et al.

    A new method of developing expert consensus practice guidelines

    Am J Manag Care

    (1998)
  • D.A. Kahn et al.

    The expert consensus guideline series: treatment of bipolar disorder

    J Clin Psychiatry

    (1996)
  • J.P. McEvoy et al.

    The expert consensus guideline series: treatment of schizophrenia

    J Clin Psychiatry

    (1996)
  • J.S. March et al.

    The expert consensus guideline series: treatment of obsessive-compulsive disorder

    J Clin Psychiatry

    (1997)
  • Alexopoulos GS, Silver JM, Kahn DA, Frances A, Carpenter D. The expert consensus guideline series: treatment of...
  • J.P. McEvoy et al.

    The expert consensus guideline series: treatment of schizophrenia 1999

    J Clin Psychiatry

    (1999)
  • Cited by (0)

    This supplement was edited and designed by Ruth Ross, MA, and David Ross, MA, MCE, Ross Editorial.

    View full text